Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Cervix (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Kentucky3


Oklahoma6


Mississippi6


Louisiana3


Florida6


West Virginia6


Arkansas6


Texas3


Puerto Rico6


Georgia3


Missouri6


Kansas6


South Carolina6


Alabama6


Ohio6


New Jersey3


Tennessee6


New York3


California3


Iowa3


North Carolina6


New Mexico3


Illinois3


Idaho3


Pennsylvania6


Wyoming6


South Dakota6


Montana6


Maryland6


Hawaii3


Michigan6


District of Columbia6


North Dakota6


Delaware6


Utah3


Nebraska6


Rhode Island6


Washington5


Alaska6


Virginia6


Wisconsin6


Oregon6


Connecticut3


Maine6


Arizona6


Colorado6


Massachusetts3


Vermont6


New Hampshire6


Minnesota6


Indiana6 Nevada6

Notes:
Created by statecancerprofiles.cancer.gov on 06/20/2024 10:30 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.